Breast Cancer Diagnostics Market Size, and Share Report Analysis 2032

Breast Cancer Diagnostics Market

Breast Cancer Diagnostics Market - By Type (Imaging, Blood Tests, Genomic Tests, and Biopsy), By Product (Platform-based and Instrument-Based), and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2024 - 2032-

Category: Biotechnology Report Format : PDF Pages: 130 Report Code: ZMR-6535 Published Date: Nov-2024 Status : Published
Market Size in 2023 Market Forecast in 2032 CAGR (in %) Base Year
USD 4.42 Billion USD 8.27 Billion 7.2% 2023

Table Of Content

  • Chapter 1. Preface
    • 1.1. Report Description and Scope
    • 1.2. Research Scope
    • 1.3. Research Methodology
      • 1.3.1. Market Research Type
      • 1.3.2. Market Research Methodology
  • Chapter 2. Executive Summary
    • 2.1. Breast Cancer Diagnostics Market, 2018–2028(USD Billion)
    • 2.2. Breast Cancer Diagnostics Market: Snapshot
  • Chapter 3. Global Breast Cancer Diagnostics Market– Industry Analysis
    • 3.1. Breast Cancer Diagnostics Market: Market Dynamics
    • 3.2. Market Drivers
      • 3.2.1. A significant decrease in breast-cancer related demises in countries such as the U.S. from 1975 to 2000 owing to consistent improvement in breast cancer diagnostic procedures will enhance breast cancer diagnostics market expansion within a couple of years.
      • 3.2.2. Early & quick detection of breast cancer tumors or cell tissues will lead to rise in rate of survival of patients through immediate & effective treatment of the disease, thereby embellishing industry space.
    • 3.3. Porter’s Five Forces Analysis
    • 3.4. Market Attractiveness Analysis
      • 3.4.1. Market attractiveness analysis By Type
      • 3.4.2. Market attractiveness analysis By Product
  • Chapter 4. Global Breast Cancer Diagnostics Market– Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global Breast Cancer Diagnostics Market: company market share, 2019
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New Technology launches
      • 4.2.3. Agreements, partnerships, cullaborations, and joint ventures
      • 4.2.4. Research and development and Regional expansion
    • 4.3. Price trend analysis
  • Chapter 5. Global Breast Cancer Diagnostics Market– Type Analysis
    • 5.1. Global Breast Cancer Diagnostics Market overview: By Type
      • 5.1.1. Global Breast Cancer Diagnostics Market share, By Type, 2020 and 2028
    • 5.2. Imaging
      • 5.2.1. Global Breast Cancer Diagnostics Market by Imaging, 2018–2028(USD Billion)
    • 5.3. Blood Tests
      • 5.3.1. Global Breast Cancer Diagnostics Market by Blood Tests, 2018–2028(USD Billion)
    • 5.4. Genomic Tests
      • 5.4.1. Global Breast Cancer Diagnostics Market by Genomic Tests, 2018–2028(USD Billion)
    • 5.5. Biopsy
      • 5.5.1. Global Breast Cancer Diagnostics Market by Biopsy, 2018–2028(USD Billion)
  • Chapter 6. Global Breast Cancer Diagnostics Market– Product Analysis
    • 6.1. Global Breast Cancer Diagnostics Market overview: By Product
      • 6.1.1. Global Breast Cancer Diagnostics Market share, By Product, 2020 and 2028
    • 6.2. Platform-based
      • 6.2.1. Global Breast Cancer Diagnostics Market by Platform-based , 2018–2028(USD Billion)
    • 6.3. Instrument-based
      • 6.3.1. Global Breast Cancer Diagnostics Market by Instrument-based, 2018–2028(USD Billion)
  • Chapter 7. Company Profiles
    • 7.1. Hulogic Inc.
      • 7.1.1. Overview
      • 7.1.2. Financials
      • 7.1.3. Technology Portfolio
      • 7.1.4. Business Strategy
      • 7.1.5. Recent Developments
    • 7.2. Danaher Corporation
      • 7.2.1. Overview
      • 7.2.2. Financials
      • 7.2.3. Technology Portfolio
      • 7.2.4. Business Strategy
      • 7.2.5. Recent Developments
    • 7.3. QIANGEN N.V.
      • 7.3.1. Overview
      • 7.3.2. Financials
      • 7.3.3. Technology Portfolio
      • 7.3.4. Business Strategy
      • 7.3.5. Recent Development
    • 7.4. Koninklijke Philips N.V.
      • 7.4.1. Overview
      • 7.4.2. Financials
      • 7.4.3. Technology Portfolio
      • 7.4.4. Business Strategy
      • 7.4.5. Recent Development
    • 7.5. F. Hoffmann-La Roche Limited
      • 7.5.1. Overview
      • 7.5.2. Financials
      • 7.5.3. Technology Portfolio
      • 7.5.4. Business Strategy
      • 7.5.5. Recent Development
    • 7.6. Argon Medical Devices, Inc.
      • 7.6.1. Overview
      • 7.6.2. Financials
      • 7.6.3. Technology Portfolio
      • 7.6.4. Business Strategy
      • 7.6.5. Recent Development
    • 7.7. BD
      • 7.7.1. Overview
      • 7.7.2. Financials
      • 7.7.3. Technology Portfolio
      • 7.7.4. Business Strategy
      • 7.7.5. Recent Development

Table Of Figures

List of Figures

1. Market research Type
2. Market research methodology
3. Global Breast Cancer Diagnostics Market, 2018–2028(USD Billion)
4. Porter’s Five Forces Analysis
5. Global Breast Cancer Diagnostics Marketattractiveness, By Type
6. Global Breast Cancer Diagnostics Marketattractiveness, By Product
7. Global Breast Cancer Diagnostics Marketshare by Type ,2020 and 2028 (USD Billion)
8. Global Breast Cancer Diagnostics Marketby Imaging, 2018–2028(USD Billion)
9. Global Breast Cancer Diagnostics Marketby Blood Tests, 2018–2028(USD Billion)
10. Global Breast Cancer Diagnostics Marketby Genomic Tests, 2018–2028(USD Billion)
11. Global Breast Cancer Diagnostics Marketby Biopsy, 2018–2028(USD Billion)
12. Global Breast Cancer Diagnostics Marketshare by Product ,2020 and 2028 (USD Billion)
13. Global Breast Cancer Diagnostics Marketby Platform-based , 2018–2028(USD Billion)
14. Global Breast Cancer Diagnostics Marketby Instrument-based, 2018–2028(USD Billion)
15. Global Breast Cancer Diagnostics Marketshare, by Region, 2020 and 2028
16. North America Breast Cancer Diagnostics Market, 2018–2028(USD Billion)
17. Europe Breast Cancer Diagnostics Market, 2018–2028(USD Billion)
18. Asia Pacific Breast Cancer Diagnostics Market, 2018–2028(USD Billion)
19. Latin America Breast Cancer Diagnostics Market, 2018–2028(USD Billion)
20. The Middle East and Africa Breast Cancer Diagnostics Market, 2018–2028(USD Billion)
 


Table Of Tables

List of Tables

1. Global Breast Cancer Diagnostics Market: snapshot
2. Drivers of the Breast Cancer Diagnostics Market: impact analysis
3. North America Breast Cancer Diagnostics Market revenue, By Type  ,2018–2028(USD Billion)
4. North America Breast Cancer Diagnostics Market revenue, By Product  ,2018–2028(USD Billion)
5. The U.S. Breast Cancer Diagnostics Market revenue, By Type  ,2018–2028(USD Billion)
6. The U.S. Breast Cancer Diagnostics Market revenue, By Product  ,2018–2028(USD Billion)
7. Rest of North America Breast Cancer Diagnostics Market revenue, By Type  ,2018–2028(USD Billion)
8. Rest of North America Breast Cancer Diagnostics Market revenue, By Product  ,2018–2028(USD Billion)
9. Europe Breast Cancer Diagnostics Market revenue, By Type  ,2018–2028(USD Billion)
10. Europe Breast Cancer Diagnostics Market revenue, By Product  ,2018–2028(USD Billion)
11. UK Breast Cancer Diagnostics Market revenue, By Type  ,2018–2028(USD Billion)
12. UK Breast Cancer Diagnostics Market revenue, By Product  ,2018–2028(USD Billion)
13. France Breast Cancer Diagnostics Market revenue, By Type  ,2018–2028(USD Billion)
14. France Breast Cancer Diagnostics Market revenue, By Product  ,2018–2028(USD Billion)
15. Germany Breast Cancer Diagnostics Market revenue, By Type  ,2018–2028(USD Billion)
16. Germany Breast Cancer Diagnostics Market revenue, By Product  ,2018–2028(USD Billion)
17. Rest of Europe Breast Cancer Diagnostics Market revenue, By Type  ,2018–2028(USD Billion)
18. Rest of Europe Breast Cancer Diagnostics Market revenue, By Product  ,2018–2028(USD Billion)
19. Asia Pacific Breast Cancer Diagnostics Market revenue, By Type  ,2018–2028(USD Billion)
20. Asia Pacific Breast Cancer Diagnostics Market revenue, By Product  ,2018–2028(USD Billion)
21. China Breast Cancer Diagnostics Market revenue, By Type  ,2018–2028(USD Billion)
22. China Breast Cancer Diagnostics Market revenue, By Product  ,2018–2028(USD Billion)
23. Japan Breast Cancer Diagnostics Market revenue, By Type  ,2018–2028(USD Billion)
24. Japan Breast Cancer Diagnostics Market revenue, By Product  ,2018–2028(USD Billion)
25. India Breast Cancer Diagnostics Market revenue, By Type  ,2018–2028(USD Billion)
26. India Breast Cancer Diagnostics Market revenue, By Product  ,2018–2028(USD Billion)
27. Rest of Asia Pacific Breast Cancer Diagnostics Market revenue, By Type  ,2018–2028(USD Billion)
28. Rest of Asia Pacific Breast Cancer Diagnostics Market revenue, By Product  ,2018–2028(USD Billion)
29. Latin America Breast Cancer Diagnostics Market revenue, By Type  ,2018–2028(USD Billion)
30. Latin America Breast Cancer Diagnostics Market revenue, By Product  ,2018–2028(USD Billion)
31. Brazil Breast Cancer Diagnostics Market revenue, By Type  ,2018–2028(USD Billion)
32. Brazil Breast Cancer Diagnostics Market revenue, By Product  ,2018–2028(USD Billion)
33. Rest of Latin America Breast Cancer Diagnostics Market revenue, By Type  ,2018–2028(USD Billion)
34. Rest of Latin  America Breast Cancer Diagnostics Market revenue, By Product  ,2018–2028(USD Billion)
35. The Middle East and Africa Breast Cancer Diagnostics Market revenue, By Type  ,2018–2028(USD Billion)
36. The Middle East and Africa Breast Cancer Diagnostics Market revenue, By Product  ,2018–2028(USD Billion)
37. Saudi Arabia Breast Cancer Diagnostics Market revenue, By Type  ,2018–2028(USD Billion)
38. Saudi Arabia Breast Cancer Diagnostics Market revenue, By Product  ,2018–2028(USD Billion)
39. South Africa Breast Cancer Diagnostics Market revenue, By Type  ,2018–2028(USD Billion)
40. South Africa Breast Cancer Diagnostics Market revenue, By Product  ,2018–2028(USD Billion)
41. Rest of the Middle East & Africa Breast Cancer Diagnostics Market revenue, By Type  ,2018–2028(USD Billion)
42. Rest of the Middle East & Africa Breast Cancer Diagnostics Market revenue, By Product  ,2018–2028(USD Billion)

 
 

Methodology

FrequentlyAsked Questions

Breast cancer diagnostics involve techniques and tools used to detect and evaluate breast cancer. Common methods include imaging tests like mammograms, ultrasounds, and MRIs, as well as biopsies and molecular tests to determine the presence, type, and stage of the disease.

According to study, the Breast Cancer Diagnostics Market size was worth around USD 4.42 billion in 2023 and is predicted to grow to around USD 8.27 billion by 2032.

The CAGR value of Breast Cancer Diagnostics Market is expected to be around 7.2% during 2024-2032.

North America has been leading the Breast Cancer Diagnostics Market and is anticipated to continue on the dominant position in the years to come.

The Breast Cancer Diagnostics Market is led by players like Hologic Inc., Danaher Corporation, QIANGEN N.V., Koninklijke Philips N.V., F. Hoffmann-La Roche Limited, Argon Medical Devices Inc., and BD.

Choose License Type

  • zion payment modes

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

twitter

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed